Literature DB >> 8638164

TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction.

H Shibuya1, K Yamaguchi, K Shirakabe, A Tonegawa, Y Gotoh, N Ueno, K Irie, E Nishida, K Matsumoto.   

Abstract

Transforming growth factor-beta (TGF-beta) regulates many aspects of cellular function. A member of the mitogen-activated protein kinase kinase kinase (MAPKKK) family, TAK1, was previously identified as a mediator in the signaling pathway of TGF-beta superfamily members. The yeast two-hybrid system has now revealed two human proteins, termed TAB1 and TAB2 (for TAK1 binding protein), that interact with TAK1. TAB1 and TAK1 were co-immunoprecipitated from mammalian cells. Overproduction of TAB1 enhanced activity of the plasminogen activator inhibitor 1 gene promoter, which is regulated by TGF-beta, and increased the kinase activity of TAK1. TAB1 may function as an activator of the TAK1 MAPKKK in TGF-beta signal transduction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8638164     DOI: 10.1126/science.272.5265.1179

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  169 in total

1.  Effect of vitamin E succinate on expression of TGF-beta1, c-Jun and JNK1 in human gastric cancer SGC-7901 cells.

Authors:  K Wu; B H Liu; D Y Zhao; Y Zhao
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Autoactivation of transforming growth factor beta-activated kinase 1 is a sequential bimolecular process.

Authors:  Roland Scholz; Corinne L Sidler; Ramon F Thali; Nicolas Winssinger; Peter C F Cheung; Dietbert Neumann
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

Review 3.  Control of plant cytokinesis by an NPK1-mediated mitogen-activated protein kinase cascade.

Authors:  Takashi Soyano; Masaki Ishikawa; Ryuichi Nishihama; Satoshi Araki; Mayumi Ito; Masaki Ito; Yasunori Machida
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-06-29       Impact factor: 6.237

4.  NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor.

Authors:  Abel Martin-Garrido; David I Brown; Alicia N Lyle; Anna Dikalova; Bonnie Seidel-Rogol; Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2010-11-11       Impact factor: 7.376

Review 5.  Structural insights into the assembly of large oligomeric signalosomes in the Toll-like receptor-interleukin-1 receptor superfamily.

Authors:  Ryan Ferrao; Jixi Li; Elisa Bergamin; Hao Wu
Journal:  Sci Signal       Date:  2012-05-29       Impact factor: 8.192

6.  Feedback control of the protein kinase TAK1 by SAPK2a/p38alpha.

Authors:  Peter C F Cheung; David G Campbell; Angel R Nebreda; Philip Cohen
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

7.  NRAGE mediates p38 activation and neural progenitor apoptosis via the bone morphogenetic protein signaling cascade.

Authors:  Stephen E Kendall; Chiara Battelli; Sarah Irwin; Jane G Mitchell; Carlotta A Glackin; Joseph M Verdi
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

8.  Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK.

Authors:  Chie Kanei-Ishii; Jun Ninomiya-Tsuji; Jun Tanikawa; Teruaki Nomura; Tohru Ishitani; Satoshi Kishida; Kenji Kokura; Toshihiro Kurahashi; Emi Ichikawa-Iwata; Yongsok Kim; Kunihiro Matsumoto; Shunsuke Ishii
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

9.  Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway.

Authors:  Taisuke Kajino; Hong Ren; Shun-Ichiro Iemura; Tohru Natsume; Bjarki Stefansson; David L Brautigan; Kunihiro Matsumoto; Jun Ninomiya-Tsuji
Journal:  J Biol Chem       Date:  2006-11-01       Impact factor: 5.157

10.  A genetic screen targeting the tumor necrosis factor/Eiger signaling pathway: identification of Drosophila TAB2 as a functionally conserved component.

Authors:  Peter Geuking; Rajesh Narasimamurthy; Konrad Basler
Journal:  Genetics       Date:  2005-08-03       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.